In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Presidential Address - EAPCI Newsletter August 2009

"It is now time for me to warm heartedly wish the upcoming President, great success."

William Wijns

While we are looking forward to a successful ESC Congress in Barcelona, we would like to draw your attention to an important event for our Association. On Monday 31 August 2009 (from 15:30 till 16:30, Room 1, Zone 3, ESC Central, 1st floor), the presidency of the European Association for Percutaneous Cardiovascular Interventions will be handed over for two years to the newly elected Board, under the leadership of Carlo Di Mario.

The creation of the EAPCI resulted in a coalition of forces, consolidating the essential existing assets: a great annual EuroPCR congress, a growing top quality EuroIntervention journal, now listed in MedLine, and two booming website portals.

After 3 years of existence, the newly elected Board will expand the activities, by strengthening the new initiatives, as well as launching a number of exciting new projects.

  • Stent for Life will continue to encourage the delivery of life saving interventions to patients presenting with acute coronary artery disease. The project is entering a decisive phase with the start of implementation pilot projects in specific countries.
  • SHARE, the acronym for “Sustain Health development in Africa through Responsible Education” is moving slowly but surely, with continued efforts in Mauritania, and potentially new programs to be started in the next few years.
  • EAPCI and EuroPCR will engage further into experimental and clinical research. Our aim will be to ensure scientifically sound and clinically relevant choices for trial design and the evaluation and implementation of innovative therapies. In keeping with the great contributions from the past, the next generation will have to continue to materialise the European added value in the field of interventional cardiology.
  • Registries under the framework of the ESC Euro Heart Survey programs will be rekindled and benefit from renewed enthusiasm by focusing on specific, timely topics.
  • Lastly, the thinking on subspecialty accreditation and revalidation continues to evolve. This area is the greatest excellent opportunity for EAPCI and National Societies to join forces, aiming at raising the quality of training and practice across Europe.

A more detailed description of the ambitious plans of the new presidential office can be found in a recent article published in EuroIntervention (Presidential Criss-Cross. The transfer of office between EAPCI presidents, EuroIntervention 2009;5:1-3).

On a personal basis, I would like to personally thank all of you who generously donated time to EAPCI. Last but not least, I gladly acknowledge that none of this would have happened without the dedication and expertise of the staff at the Heart House and Europa Organisation.

It is now time for me to warmheartedly wish the upcoming President great success. I trust that his new office will be able to count on the dedication and commitment of all of you, as much as I could during the last three years.

William Wijns
Immediate Past-President EAPCI, 2009-2011